Surface Oncology Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 51
Employees
  • Stock Symbol
  • SURF
Stock Symbol
  • Share Price
  • $7.33
  • (As of Monday Closing)

Surface Oncology General Information

Description

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out through the region of the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 50 Hampshire Street
  • 8th Floor
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Surface Oncology Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.33 $7.31 $2.39 - $14.40 $318M 43.4M 1.54M $1.67

Surface Oncology Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 322,836 322,836 (38,504) (56,004)
Revenue 126,162 126,162 15,360 59,417
EBITDA 63,256 63,256 (55,581) (7,804)
Net Income 59,337 59,337 (54,789) (6,597)
Total Assets 217,138 217,138 131,693 174,065
Total Debt 49,269 49,269 25,039 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Surface Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Surface Oncology‘s full profile, request access.

Request a free trial

Surface Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Surface Oncology‘s full profile, request access.

Request a free trial

Surface Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces
Drug Discovery
Cambridge, MA
51 As of 2020
00000
000000 - 000 00000

000000 0

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000

0000 000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000 000000000
San Diego, CA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Surface Oncology Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jounce Therapeutics Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 Formerly VC-backed La Jolla, CA 00 00000 00000000 00000
00000 000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 18 competitors. Get the full list »

Surface Oncology Executive Team (14)

Name Title Board Seat Contact Info
Jeffrey Goater Chief Executive Officer & Board Member
Jessica Fees Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Liisa Nogelo Chief Legal Officer
Vito Palombella Chief Scientific Officer
Wendy Dwyer Executive
You’re viewing 5 of 14 executive team members. Get the full list »

Surface Oncology Board Members (14)

Name Representing Role Since
Armen Shanafelt Ph.D Lilly Ventures Board Member 000 0000
Chris Klee Self Board Observer 000 0000
Daniel Lynch Surface Oncology Chairman & Board Member 000 0000
David Grayzel MD Atlas Venture Founder & Board Member 000 0000
Elliott Sigal Ph.D New Enterprise Associates Board Member & Member of Nominating, Corporate Governance Committee 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Surface Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Surface Oncology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Surface Oncology‘s full profile, request access.

Request a free trial